Taking these results together, we presumed that within invasive breast cancer environments, cell surface annexin A2 on the TNBC cells prefers interaction with the highly expressed S100A11 to that with S100A10; this complex then functions as a receptor of plasminogen, where the immature type is transformed into active plasmin. The gene discussed is ANXA2; the disease is breast carcinoma.